1	The	the	_	_	_	_	_	_	_
2	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
3	virus	virus	_	_	_	_	_	_	_
4	latency	latency	_	_	_	_	_	_	_
5	BamHI-Q	BamHI-Q	_	_	_	_	_	_	_
6	promoter	promoter	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	positively	positively	_	_	_	_	_	_	_
9	regulated	regulate	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	STATs	STAT	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	Zta	Zta	_	_	_	_	_	_	_
14	interference	interference	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	JAK/STAT	jak/stat	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	leads	lead	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	loss	loss	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	BamHI-Q	BamHI-Q	_	_	_	_	_	_	_
23	promoter	promoter	_	_	_	_	_	_	_
24	activity	activity	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
3	virus	virus	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	EBV)-associated	ebv)-associated	_	_	_	_	_	_	_
6	tumors	tumor	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	nonimmunocompromised	nonimmunocompromised	_	_	_	_	_	_	_
9	patients	patient	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	EBV	EBV	_	_	_	_	_	_	_
12	gene	gene	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	is	be	_	_	_	_	_	_	_
15	highly	highly	_	_	_	_	_	_	_
16	restricted	restricted	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	EBV-encoded	ebv-encoded	_	_	_	_	_	_	_
2	nuclear	nuclear	_	_	_	_	_	_	_
3	antigen	antigen	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	EBNA)-1	EBNA)-1	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	expressed	express	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	whereas	whereas	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	immunogenic	immunogenic	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	proliferative	proliferative	_	_	_	_	_	_	_
14	EBNAs	ebna	_	_	_	_	_	_	_
15	are	be	_	_	_	_	_	_	_
16	not	not	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	pattern	pattern	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	EBNA	EBNA	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	generated	generate	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	usage	usage	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	BamHI-Q	BamHI-Q	_	_	_	_	_	_	_
13	promoter	promoter	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	Qp	Qp	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	determined	determine	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	JAK/STAT	JAK/STAT	_	_	_	_	_	_	_
7	pathway	pathway	_	_	_	_	_	_	_
8	positively	positively	_	_	_	_	_	_	_
9	regulates	regulate	_	_	_	_	_	_	_
10	Qp	Qp	_	_	_	_	_	_	_
11	activity	activity	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	transient-transfection	transient-transfection	_	_	_	_	_	_	_
3	assays	assay	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	Qp-CAT	Qp-CAT	_	_	_	_	_	_	_
7	reporter	reporter	_	_	_	_	_	_	_
8	was	be	_	_	_	_	_	_	_
9	activated	activate	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	cotransfected	cotransfecte	_	_	_	_	_	_	_
12	JAK-1	jak-1	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	treatment	treatment	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	cytokine	cytokine	_	_	_	_	_	_	_
21	IL-6	il-6	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	ability	ability	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	Qp	Qp	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	bind	bind	_	_	_	_	_	_	_
7	signal	signal	_	_	_	_	_	_	_
8	transducer	transducer	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	activator	activator	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	transcription	transcription	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	STAT	STAT	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	proteins	protein	_	_	_	_	_	_	_
17	was	be	_	_	_	_	_	_	_
18	directly	directly	_	_	_	_	_	_	_
19	demonstrated	demonstrate	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	electrophoretic	electrophoretic	_	_	_	_	_	_	_
22	mobility-shift	mobility-shift	_	_	_	_	_	_	_
23	assay	assay	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	mutation	mutation	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	potential	potential	_	_	_	_	_	_	_
29	STAT-binding	stat-binding	_	_	_	_	_	_	_
30	sites	site	_	_	_	_	_	_	_
31	reduced	reduce	_	_	_	_	_	_	_
32	Qp	Qp	_	_	_	_	_	_	_
33	responsiveness	responsiveness	_	_	_	_	_	_	_
34	to	to	_	_	_	_	_	_	_
35	Janus	Janus	_	_	_	_	_	_	_
36	kinase	kinase	_	_	_	_	_	_	_
37	(	(	_	_	_	_	_	_	_
38	JAK)-1	JAK)-1	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	Consistent	consistent	_	_	_	_	_	_	_
2	with	with	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	role	role	_	_	_	_	_	_	_
5	for	for	_	_	_	_	_	_	_
6	STATs	stat	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	Qp	Qp	_	_	_	_	_	_	_
9	function	function	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	Qp	Qp	_	_	_	_	_	_	_
12	using	use	_	_	_	_	_	_	_
13	Burkitt	Burkitt	_	_	_	_	_	_	_
14	â€™s	's	_	_	_	_	_	_	_
15	lymphoma	lymphoma	_	_	_	_	_	_	_
16	Rael	Rael	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	cultured	culture	_	_	_	_	_	_	_
20	nasopharyngeal	nasopharyngeal	_	_	_	_	_	_	_
21	carcinoma	carcinoma	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	NPC	NPC	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	contained	contain	_	_	_	_	_	_	_
27	nuclear	nuclear	_	_	_	_	_	_	_
28	STAT	stat	_	_	_	_	_	_	_
29	protein	protein	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	investigated	investigate	_	_	_	_	_	_	_
3	whether	whether	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	inability	inability	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	maintain	maintain	_	_	_	_	_	_	_
8	EBV-positive	ebv-positive	_	_	_	_	_	_	_
9	NPC	NPC	_	_	_	_	_	_	_
10	cell	cell	_	_	_	_	_	_	_
11	lines	line	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	culture	culture	_	_	_	_	_	_	_
14	was	be	_	_	_	_	_	_	_
15	related	related	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	Qp	qp	_	_	_	_	_	_	_
18	activity	activity	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Passaging	passaging	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	NPC	NPC	_	_	_	_	_	_	_
5	cell	cell	_	_	_	_	_	_	_
6	line	line	_	_	_	_	_	_	_
7	HK666	hk666	_	_	_	_	_	_	_
8	led	lead	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	BZLF1	BZLF1	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	which	which	_	_	_	_	_	_	_
17	encodes	encode	_	_	_	_	_	_	_
18	Zta	Zta	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	loss	loss	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	Qp	Qp	_	_	_	_	_	_	_
23	function	function	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Transient	transient	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	assays	assay	_	_	_	_	_	_	_
4	linked	link	_	_	_	_	_	_	_
5	Zta	Zta	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	down-regulation	down-regulation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	Qp	Qp	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Cotransfection	Cotransfection	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	Zta	Zta	_	_	_	_	_	_	_
4	reduced	reduce	_	_	_	_	_	_	_
5	Qp	Qp	_	_	_	_	_	_	_
6	activity	activity	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	reporter	reporter	_	_	_	_	_	_	_
9	assays	assay	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	negative	negative	_	_	_	_	_	_	_
3	regulation	regulation	_	_	_	_	_	_	_
4	required	require	_	_	_	_	_	_	_
5	Zta	Zta	_	_	_	_	_	_	_
6	DNA-binding	dna-binding	_	_	_	_	_	_	_
7	activity	activity	_	_	_	_	_	_	_
8	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	provide	provide	_	_	_	_	_	_	_
3	evidence	evidence	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	Zta	Zta	_	_	_	_	_	_	_
6	up-regulation	up-regulation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	p53	p53	_	_	_	_	_	_	_
9	leads	lead	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	p53-mediated	p53-mediated	_	_	_	_	_	_	_
12	interference	interference	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	JAK/STAT	JAK/STAT	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	Qp	Qp	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	imply	imply	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	JAK/STAT	jak/stat	_	_	_	_	_	_	_
6	signaling	signaling	_	_	_	_	_	_	_
7	has	have	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	role	role	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	EBV-associated	ebv-associated	_	_	_	_	_	_	_
12	malignancies	malignancy	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

